InduPro
Michael Warren has extensive work experience in the pharmaceutical and biotechnology industry. Michael started their career at ArQule, Inc as a Research Scientist, where they developed cell proliferation and cytotoxicity assays. Michael then joined NitroMed as a Senior Research Associate, specializing in studying nitric-oxide metabolomics for small molecule vascular drug discovery. After that, they worked at Pfizer Pharmaceuticals as a Research Scientist II, focusing on GPCR targets and new technologies in the areas of diabetes and metabolic disease. Following Pfizer, they joined FORMA Therapeutics as a Principal Research Associate. In 2015, they joined Surface Oncology Inc, where they served in various roles including Scientist, Senior Scientist, and Principal Scientist. Most recently, they worked at InduPro as a Principal Scientist.
Michael Warren earned a Bachelor of Science degree in Biochemistry from the University of New Hampshire, completing their studies from 1992 to 1996. Following that, they pursued a Master of Science degree in Biotechnology/Biology at the University of Massachusetts Lowell, from 1996 to 1999.
This person is not in any offices
InduPro
InduPro is bringing life-changing therapies to patients through novel cell-surface platform technologies. We are defining and manipulating protein interactions beyond natural signaling paradigms. InduPro platforms, integrate inherent protein proximity at the cell surface with the ability to manipulate protein pairings via induced protein proximity to create novel signaling pathways and logic gates.